Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Good

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|March 13, 1970
Letters to the editorR H Good
Nature|November 25, 1993
Evolution and religionR H Good
Journal of Consulting and Clinical Psychology|June 1, 1990
Hypothesis validity of clinical researchB E Wampold, B Davis, R H Good
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1970
Synthesis of polynuclear heterocycles. II. Cyclisations of 2- and 4-substituted 3-amino- and 3-nitro-pyridinesJ J Eatough, L S Fuller, R H Good, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancerS E Jones, M W Schottstaedt, L A Duncan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|March 13, 1970
Letters to the editorR H Good
Nature|November 25, 1993
Evolution and religionR H Good
Journal of Consulting and Clinical Psychology|June 1, 1990
Hypothesis validity of clinical researchB E Wampold, B Davis, R H Good
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1970
Synthesis of polynuclear heterocycles. II. Cyclisations of 2- and 4-substituted 3-amino- and 3-nitro-pyridinesJ J Eatough, L S Fuller, R H Good, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancerS E Jones, M W Schottstaedt, L A Duncan, et al.
Pageof 1